RANI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RANI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Rani Therapeutics Holdings's other long-term assets for the quarter that ended in Sep. 2024 was $0.25 Mil.
Rani Therapeutics Holdings's quarterly other long-term assets stayed the same from Mar. 2024 ($0.25 Mil) to Jun. 2024 ($0.25 Mil) and stayed the same from Jun. 2024 ($0.25 Mil) to Sep. 2024 ($0.25 Mil).
Rani Therapeutics Holdings's annual other long-term assets stayed the same from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($-0.00 Mil) but then increased from Dec. 2022 ($-0.00 Mil) to Dec. 2023 ($0.25 Mil).
The historical data trend for Rani Therapeutics Holdings's Other Long Term Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rani Therapeutics Holdings Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Other Long Term Assets | 1.63 | - | - | - | 0.25 |
Rani Therapeutics Holdings Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Other Long Term Assets | Get a 7-Day Free Trial | - | 0.25 | 0.25 | 0.25 | 0.25 |
GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.
Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.
South Cone Investments Limited Partnership | 10 percent owner | AVENIDA PRESIDENTE RIESCO 5711 OFICINA 1, LAS CONDES, SANTIAGO F3 7550000 |
Talat Imran | director, officer: CEO | C/O RANI THERAPEUTICS HOLDINGS, INC., 2051 RINGWOOD AVENUE, SAN JOSE CA 95131 |
Quiroga Cortes Isidoro Alfonso | 10 percent owner | 9020 N CAPITAL OF TEXAS HWY, SUITE I-260, AUSTIN TX 78759 |
Jean Luc Butel | director | ONE BAXTER PARKWAY, DEERFIELD IL 60015 |
Maulik Nanavaty | director | BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234 |
Kate Mckinley | officer: CHIEF BUSINESS OFFICER | C/O RANI THERAPEUTICS HOLDINGS, INC., 2051 RINGWOOD AVE., SAN JOSE CA 95131 |
Svai S Sanford | officer: CFO | C/O RANI THERAPEUTICS LLC, 2051 RINGWOOD AVE., SAN JOSE CA 95131 |
Eric Groen | officer: General Counsel | C/O RANI THERAPEUTICS HOLDINGS, INC., 2051 RINGWOOD AVE., SAN JOSE CA 95131 |
Mir Hashim | officer: Chief Scientific Officer | C/O RANI THERAPEUTICS HOLDINGS, INC., 2051 RINGWOOD AVENUE, SAN JOSE CA 95131 |
South Lake One Llc | 10 percent owner | 250 WEST 55TH STREET, NEW YORK NY 10019 |
Aequanimitas Limited Partnership | 10 percent owner | LEONEL AGUIRRE 1830, UNIT 101, MONTEVIDEO X3 11500 |
Mir A Imran | director | |
Andrew Farquharson | director | C/O RANI THERAPEUTICS HOLDINGS, INC., 2051 RINGWOOD AVENUE, SAN JOSE CA 95131 |
Laureen Debuono | director | |
Lisa Ann Rometty | director | C/O RANI THERAPEUTICS HOLDINGS, INC., 2051 RINGWOOD AVE., SAN JOSE CA 95131 |
From GuruFocus
By GuruFocus Research • 05-08-2024
By GuruFocus Research • 02-08-2024
By Marketwired • 10-12-2023
By GuruFocus Research • 02-08-2024
By Marketwired • 10-19-2023
By PRNewswire • 01-09-2024
By GuruFocus Research • 02-08-2024
By Marketwired • 10-15-2024
By Marketwired • 08-06-2024
By GuruFocus Research • 11-08-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.